Skip to main content
Year archive

VALIRX PLC — 2018 filings

All 41 regulatory filings released by VALIRX PLC (VAL) in 2018, sourced directly from the official regulator.

41 Filings
2018 Period
2018 filings (41)
Filing Released Lang
Second Price Monitoring Extn
Regulatory Filings
2018-12-18 English
Price Monitoring Extension
Regulatory Filings
2018-12-18 English
Issue of Equity / PDMR Shareholdings
Regulatory Filings
2018-12-18 English
Update on VAL401 - Peer-review Acceptance
Regulatory Filings
2018-12-18 English
Update on VAL201 Clinical Trial
Regulatory Filings
2018-12-10 English
Re scientific and investor meetings
Report Publication Announcement
2018-11-05 English
Hardman & Co Research: ValiRx (VAL): VAL401 Phase II trial completed
Regulatory Filings
2018-11-01 English
Align Research Initiates Coverage
Regulatory Filings
2018-10-24 English
VAL201 in concluding stages of Phase I/II trial
Regulatory Filings
2018-10-17 English
VAL401 results shortly to be on ClinicalTrials.gov
Regulatory Filings
2018-10-15 English
Half-year Report
Interim / Quarterly Report H1 2018
2018-09-25 English
Result of General Meeting
AGM Information
2018-07-24 English
US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301
Legal Proceedings Report
2018-07-17 English
Notice of GM
Regulatory Filings
2018-07-06 English
VAL401 Update
Regulatory Filings
2018-06-14 English
Price Monitoring Extension
Regulatory Filings
2018-05-24 English
Holding(s) in Company
Major Shareholding Notification
2018-05-11 English
Second Price Monitoring Extn
Regulatory Filings
2018-05-04 English
Price Monitoring Extension
Regulatory Filings
2018-05-04 English
Placing and grant of warrants
Regulatory Filings
2018-05-04 English
Second Price Monitoring Extn
Regulatory Filings
2018-04-26 English
Price Monitoring Extension
Regulatory Filings
2018-04-26 English
Second Price Monitoring Extn
Regulatory Filings
2018-04-25 English
Price Monitoring Extension
Regulatory Filings
2018-04-25 English
EU Patent Grant for Therapeutic Compound, VAL201
Regulatory Filings
2018-04-25 English
Hardman & Co Research: ValiRx (VAL): 2017: a pivotal year
Report Publication Announcement
2018-04-20 English
GENEICE & VAL101 Update
Regulatory Filings
2018-04-19 English
Notice of AGM
Report Publication Announcement
2018-04-12 English
Final Results
Annual Report FY 2017
2018-04-10 English
US Patent Grant for Therapeutic Compound, VAL201
Legal Proceedings Report
2018-03-20 English
Holding(s) in Company
Major Shareholding Notification
2018-03-19 English
Appointment of Broker
Board/Management Information
2018-03-16 English
Statement re broker
Legal Proceedings Report
2018-03-02 English
Issue of options and directors dealings
Director's Dealing
2018-02-09 English
Holding(s) in Company
Major Shareholding Notification
2018-02-02 English
Holding(s) in Company
Major Shareholding Notification
2018-01-25 English
Holding(s) in Company
Major Shareholding Notification
2018-01-23 English
ValiSeek Clinical Update (VAL401)
Regulatory Filings
2018-01-16 English
US Patent Notice of Allowance for Compound VAL201
Regulatory Filings
2018-01-11 English
Holding(s) in Company
Major Shareholding Notification
2018-01-04 English
Exercise of Warrants and Issue of Equity
Regulatory Filings
2018-01-03 English